Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Maranzano

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Clinics in Geriatric Medicine|October 9, 2022
Polypharmacy in OncologyJustin J Cheng, Asal M Azizoddin, Michael J Maranzano, et al.
Blood Cancer Journal|November 7, 2024
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphomaRossana Di Staso, Beatrice Casadei, Frederick L Locke, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Clinics in Geriatric Medicine|October 9, 2022
Polypharmacy in OncologyJustin J Cheng, Asal M Azizoddin, Michael J Maranzano, et al.
Blood Cancer Journal|November 7, 2024
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphomaRossana Di Staso, Beatrice Casadei, Frederick L Locke, et al.
Pageof 1